386 related articles for article (PubMed ID: 11375776)
1. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
Hoare SR; Usdin TB
Curr Pharm Des; 2001 May; 7(8):689-713. PubMed ID: 11375776
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants of tuberoinfundibular peptide of 39 residues (TIP39) selectivity for the parathyroid hormone-2 (PTH2) receptor. N-terminal truncation of TIP39 reverses PTH2 receptor/PTH1 receptor binding selectivity.
Hoare SR; Clark JA; Usdin TB
J Biol Chem; 2000 Sep; 275(35):27274-83. PubMed ID: 10854439
[TBL] [Abstract][Full Text] [Related]
3. Transcript expression of the tuberoinfundibular peptide (TIP)39/PTH2 receptor system and non-PTH1 receptor-mediated tonic effects of TIP39 and other PTH2 receptor ligands in renal vessels.
Eichinger A; Fiaschi-Taesch N; Massfelder T; Fritsch S; Barthelmebs M; Helwig JJ
Endocrinology; 2002 Aug; 143(8):3036-43. PubMed ID: 12130570
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the ligand specificity of zebrafish parathyroid hormone (PTH) receptors: comparison of PTH, PTH-related protein, and tuberoinfundibular peptide of 39 residues.
Hoare SR; Rubin DA; Jüppner H; Usdin TB
Endocrinology; 2000 Sep; 141(9):3080-6. PubMed ID: 10965877
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone and parathyroid hormone-related protein: model systems for the development of an osteoporosis therapy.
Mierke DF; Pellegrini M
Curr Pharm Des; 1999 Jan; 5(1):21-36. PubMed ID: 10066882
[TBL] [Abstract][Full Text] [Related]
6. Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity.
Hoare SR; Usdin TB
J Pharmacol Exp Ther; 2000 Nov; 295(2):761-70. PubMed ID: 11046116
[TBL] [Abstract][Full Text] [Related]
7. Molecular properties of the PTH/PTHrP receptor.
Gardella TJ; Jüppner H
Trends Endocrinol Metab; 2001 Jul; 12(5):210-7. PubMed ID: 11397646
[TBL] [Abstract][Full Text] [Related]
8. Multiple regions of ligand discrimination revealed by analysis of chimeric parathyroid hormone 2 (PTH2) and PTH/PTH-related peptide (PTHrP) receptors.
Clark JA; Bonner TI; Kim AS; Usdin TB
Mol Endocrinol; 1998 Feb; 12(2):193-206. PubMed ID: 9482662
[TBL] [Abstract][Full Text] [Related]
9. Regions in rat and human parathyroid hormone (PTH) 2 receptors controlling receptor interaction with PTH and with antagonist ligands.
Goold CP; Usdin TB; Hoare SR
J Pharmacol Exp Ther; 2001 Nov; 299(2):678-90. PubMed ID: 11602681
[TBL] [Abstract][Full Text] [Related]
10. High affinity binding of the peptide agonist TIP-39 to the parathyroid hormone 2 (PTH
Weaver RE; Mobarec JC; Wigglesworth MJ; Reynolds CA; Donnelly D
Biochem Pharmacol; 2017 Mar; 127():71-81. PubMed ID: 28012961
[TBL] [Abstract][Full Text] [Related]
11. The parathyroid hormone 2 (PTH2) receptor.
Usdin TB; Bonner TI; Hoare SR
Recept Channels; 2002; 8(3-4):211-8. PubMed ID: 12529938
[TBL] [Abstract][Full Text] [Related]
12. Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)/PTH-related peptide receptor, but functions as an antagonist.
Jonsson KB; John MR; Gensure RC; Gardella TJ; Jüppner H
Endocrinology; 2001 Feb; 142(2):704-9. PubMed ID: 11159842
[TBL] [Abstract][Full Text] [Related]
13. Transmembrane residues together with the amino terminus limit the response of the parathyroid hormone (PTH) 2 receptor to PTH-related peptide.
Turner PR; Mefford S; Bambino T; Nissenson RA
J Biol Chem; 1998 Feb; 273(7):3830-7. PubMed ID: 9461563
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the signal transduction mechanism of the parathyroid hormone 1 receptor. Effect of receptor-G-protein interaction on the ligand binding mechanism and receptor conformation.
Hoare SR; Gardella TJ; Usdin TB
J Biol Chem; 2001 Mar; 276(11):7741-53. PubMed ID: 11108715
[TBL] [Abstract][Full Text] [Related]
15. The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34).
Jüppner H; Schipani E; Bringhurst FR; McClure I; Keutmann HT; Potts JT; Kronenberg HM; Abou-Samra AB; Segre GV; Gardella TJ
Endocrinology; 1994 Feb; 134(2):879-84. PubMed ID: 8299582
[TBL] [Abstract][Full Text] [Related]
16. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
Vilardaga JP; Lin I; Nissenson RA
Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
[TBL] [Abstract][Full Text] [Related]
17. Multiple sites of contact between the carboxyl-terminal binding domain of PTHrP-(1--36) analogs and the amino-terminal extracellular domain of the PTH/PTHrP receptor identified by photoaffinity cross-linking.
Gensure RC; Gardella TJ; Jüppner H
J Biol Chem; 2001 Aug; 276(31):28650-8. PubMed ID: 11356832
[TBL] [Abstract][Full Text] [Related]
18. Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor.
Greenberg Z; Bisello A; Mierke DF; Rosenblatt M; Chorev M
Biochemistry; 2000 Jul; 39(28):8142-52. PubMed ID: 10889020
[TBL] [Abstract][Full Text] [Related]
19. Cooperative interaction of arginine-19 and the N-terminal signaling domain in the affinity and potency of parathyroid hormone.
Tsomaia N; Shimizu M; Shimizu N; Gardella TJ; Mierke DF
Biochemistry; 2004 Mar; 43(12):3459-70. PubMed ID: 15035617
[TBL] [Abstract][Full Text] [Related]
20. Development of a rat parathyroid hormone 2 receptor antagonist.
Kuo J; Usdin TB
Peptides; 2007 Apr; 28(4):887-92. PubMed ID: 17207559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
